🇺🇸 FDA
Pipeline program

Hydroxycarbamid

P15-01

Phase 2 small_molecule active

Quick answer

Hydroxycarbamid for Central Retinal Vein Occlusion, Non-Ischemic is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Central Retinal Vein Occlusion, Non-Ischemic
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials